Dr. Chami graduated from Macquarie University with a Bachelor of Medical Science with Honours (B Med Sci (Hon)). He went on to complete his Master of Pharmacy (MPharm) at the University of Sydney and his Bachelor of Medicine and Bachelor of Surgery (MBBS) at the Sydney School of Medicine, University of Notre Dame. Dr. Chami also holds a Master’s degree in Financial Management (MFM) and a Master’s degree in Business Administration (MBA) from the world-renowned Macquarie Graduate School of Management. With a remarkable list of credentials, Dr. Chami is also one of the youngest CEOs in the industry. Nonetheless, he is considered one of the most experienced, having been immersed in the industry from an early age under the tutelage of his father, Vitex Chairman Dr Elie Chami. Dr. Chami was named Manufacturing Executive of the Year in 2017 and 2018 by CEO Magazine and received the 2019 Corporate Citizen of the Year Award from Blacktown City Council. In 2024, he has capably led the business to be awarded as an Employer of Choice and was granted CEO Champion of HR Award 2024. Dr. Chami currently serves as a Board Director of Consumer Health Products (CHP) Australia, the peak body representing the manufacturers and distributors of consumer healthcare products. He is also a Board Director of the Complementary Medicines Association of Australia (CMA). Under his leadership, Vitex Pharmaceuticals has experienced rapid growth. The company has expanded its product portfolio and established strategic partnerships with some of the most respected names in the industry. These collaborations have helped to solidify Vitex’s position in the competitive pharmaceutical landscape. Spearheaded by Dr Chami, Vitex is constructing an additional state-of-the-art facility in Sydney, set to open in 2025. This expansion positions Vitex on a global trajectory, offering a full spectrum of manufacturing capabilities, including a variety of new formats. This growth cements the organisation’s status as Australia’s largest pharmaceutical contract manufacturing organisation. In addition, Dr Chami emphasises the importance of a strong company culture. Under his guidance, Vitex is known for fostering an inclusive and collaborative work environment, where creativity and scientific curiosity are celebrated. This commitment to foster an empowering work culture has allowed Vitex to attract top talent and maintain a high level of productivity. No journey to success is without its challenges, and his leadership has been defined by his ability to navigate difficult periods with resilience and foresight. His calm and decisive leadership during the global pandemic, was critical in ensuring the company continued to operate smoothly whilst prioritising the health and well-being of employees. The shift to a more digitally focused approach allowed Vitex to continue delivering essential products during a time of great uncertainty. Dr. Aniss Chami’s story is not just one of business success; it’s a testament to the power of innovation, leadership, and perseverance. As Vitex Pharmaceuticals moves into the future, it is clear that under his stewardship, Vitex will continue to create lasting change in the healthcare and pharmaceutical sectors and beyond. With a remarkable list of credentials, Dr. Chami is also one of the youngest CEOs in the industry. CEO Today Global Awards 2025 - AUSTRALIA - - 95 -
RkJQdWJsaXNoZXIy Mjk3Mzkz